APOTEX-FAMCICLOVIR famciclovir 250mg tablet blister pack

Land: Australien

Sprache: Englisch

Quelle: Department of Health (Therapeutic Goods Administration)

Wirkstoff:

famciclovir, Quantity: 250 mg

Verfügbar ab:

Arrotex Pharmaceuticals Pty Ltd

INN (Internationale Bezeichnung):

Famciclovir

Darreichungsform:

Tablet

Zusammensetzung:

Excipient Ingredients: titanium dioxide; poloxamer; macrogol 8000; hypromellose; stearic acid

Verabreichungsweg:

Oral

Einheiten im Paket:

5, 28, 14, 20, 21, 56, 30

Verschreibungstyp:

(S4) Prescription Only Medicine

Anwendungsgebiete:

Famciclovir is indicated for:. - the treatment of herpes zoster infection in adult patients who commence therapy within 72 hours of the onset of rash. Greatest benefit occurs if the drug is started within 48 hours. Efficacy has not been demonstrated in patients less than 50 years of age, although the occasional younger patient with severe herpes zoster may benefit from therapy with famciclovir. Herpes zoster infection is generally a milder condition in younger patients.. - the treatment of recurrent episodes of genital herpes in adults and adolescents 12 years of age and older.. - suppression of recurrent genital herpes.. - the treatment of recurrent herpes labialis (cold sores) in immunocompetent adult patients.. Famciclovir is indicated in immunocompromised patients for:. - treatment of uncomplicated herpes zoster;. - treatment of recurrent herpes simplex;. - suppression of recurrent herpes simplex.

Produktbesonderheiten:

Visual Identification: White, round, biconvex film-coated tablets, engraved "APO" on one side and "FAM" over "250" on the other side.; Container Type: Blister Pack; Container Material: Al/Al; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius

Berechtigungsstatus:

Licence status A

Berechtigungsdatum:

2010-05-12